Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who are able to comply with the protocol follow-up schedule
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements
Inability to comply with visit schedule or other protocol requirements.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to understand and voluntarily sign the ICF and able to comply with the study visit schedule and the other protocol requirements.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Ability and willingness to comply with the requirements of the study protocol
Able to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator are unable to comply with the safety monitoring requirements of the study
Patient must have the ability to comply with all study requirements
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Must be able to adhere to the study visit schedule and other protocol requirements.
Patients willing to comply with study requirements
Must be able to comply with the study and follow-up requirements
Subjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
If premenopausal, patient must be willing to comply with pregnancy requirements
ADJUVANT COHORT: If premenopausal, patient must be willing to comply with pregnancy requirements
Subjects must agree to adhere to all study requirements, visit schedule, outpatient treatment, required concomitant medications, and laboratory monitoring
Patients unwilling to or unable to comply with the protocol or who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Be able to comply with the requirements of the entire study.
Subject is willing and able to adhere to the study visit schedule and other protocol requirements.
Be willing to comply with clinical trial instructions and requirements.
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Agree to adhere to all study protocol requirements.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to comply with the study visit schedule and other protocol requirements.
Judgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirements.
Patient willing to conform to the study requirements
Willing and able to participate in the trial and comply with all trial requirements.
Subject is able to understand and willing to comply with protocol requirements and instructions
Willing and able to adhere to the prohibitions and restrictions specified in this protocol
Patients must be able to comply with all protocol requirements
Judgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and/or requirements.
The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment.
Must be able to adhere to the study visit schedule and other protocol requirements.
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Willing and able to comply with study requirements for follow-up
Is willing and able to adhere to the study visit schedule and other protocol requirements including blood sampling and bone marrow aspiration.
Able to adhere to study schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the study
Are willing and able to comply with the protocol requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Subject is able to understand and comply with protocol requirements and instructions
Subjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule and other protocol requirements in the opinion of the investigator.
Willingness and capability to comply with the requirements of the study.
Ability and willingness to comply with the requirements of the study protocol
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Able to comply with the study protocol, in the investigator’s judgment
Able to adhere to the study visit schedule and other protocol requirements.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Judgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirements.
Able to adhere to the study visit schedule and other protocol requirements
STUDY ENTRY: Ability and willingness to comply with the requirements of the study protocol.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to swallow the study drug and comply with study requirements
Patient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Understand and voluntarily sign informed consent prior to any study-related assessments or procedures are conducted and are able adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol.
Ability to adhere to the protocol requirements and study visit schedule.
Subject (and when applicable, with parental/legal representative) is willing and able to adhere to the study visit schedule and other protocol requirements.
Patient must be willing to give written informed consent and must be able to adhere to dosing and visit schedules, and meet all study requirements.
Able to comply with study protocol, in the investigator’s judgment
Ability and willingness to comply with the requirements of the study protocol
Ability and willingness to comply with the requirements of the study protocol
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Ability to adhere to the study visit schedule and other protocol requirements
Able to swallow the study drug, have no known intolerance to study drugs or excipients, and comply with study requirements.
Subject is able to understand and willing to comply with protocol requirements and instructions
Ability to comply with protocol requirements.
Patient, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Ability and willingness to comply with the requirements of the study protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Able to swallow sunitinib and comply with study requirements
Any other condition (e.g. psychiatric disorder) that, in the opinion of the Investigator, may interfere with the patient's ability to comply with the study requirements or visit schedule
Willingness and ability of subject to comply to study requirements
Patients who cannot comply with the study requirements
Ability and willingness to comply with the requirements of the study protocol
Ability and willingness to comply with the requirements of the study protocol
Patients unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Ability to provide informed written consent and be able to adhere to the study visit schedule and other protocol requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator may not be able to comply with IL-2 or ECP treatment requirements or the safety monitoring requirements of the study, will be excluded from participation
Ability to adhere to the study visit schedule and other protocol requirements
Any reason, at the investigator’s discretion, that the participation of the patient in this protocol would not be in patient’s best interest, or where the patient would be unable to adhere to the study requirements
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirements
Be willing to participate in the study and comply with all study requirements
Able to swallow study drug and comply with study requirements
Able to swallow study drug and comply with study requirements
Able to comply with the treatment schedule
Non-compliance; defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule and other protocol requirements
Patient has demonstrated compliance with the parent study requirements, as assessed by the principal investigator and patient is able to comply with the necessary visits and assessments as part of the rollover study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patient that is not able to understand or to comply with the study instructions and requirements, or has a history of non-compliance to the medical regimen
Patient must be able to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are NOT eligible for either Stratum
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements
Able to adhere to the study visit schedule and other protocol requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Ability to provide informed written consent and be able to adhere to the study visit schedule and other protocol requirements
Participants must be able to understand and willing to comply with protocol requirements as assessed by the investigator.
Able to understand and comply with protocol requirements for the entire length of the study
Capable of understanding the protocol requirements, is willing and able to comply with the study protocol procedures, and has signed the informed consent document.
Subject is, in the investigator’s opinion, willing and able to comply with the protocol requirements
Willing to comply with proposed visit and treatment schedule
DONOR: Able and willing to comply with the requirements of the protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to swallow study drug and comply with study requirements
Inability to comply with the safety monitoring requirements of the study, as judged by the investigator
Subject is able and willing to comply with the requirements of the protocol.
Unstable psychiatric disorder that would render the patient unable to comply with study requirements.
Unable to comply with study requirements in the opinion of the Investigator.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Willing and able to comply with all study requirements, including treatment, and attending required assessments
Negative serum or urine pregnancy tests during screening and then within 3 days prior to Day 1. 12. Sexually active men - effective contraceptive methods in subject and partner from the time of informed consent and until ? 4 weeks after discontinuing study drugs. 13. Able to adhere to the study visit schedule and other protocol requirements.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to swallow the study drug and comply with study requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
The subject is able to understand and comply with protocol requirements, timetables, instructions and protocol-stated restrictions
Ability to comply with requirements of the protocol, as assessed by the investigator by the patient signing the consent form
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Willing to adhere to and comply with all prohibitions and restrictions specified in the protocol
Research participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Participant must be willing and comply with the requirements of the protocol
Patients, who in the opinion of the investigator and another independent party, may not be able to adhere to the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to comply with the treatment schedule
Able to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator may not be able to comply with all the study requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule and other protocol requirements
Willing/able to adhere to the prohibitions and restrictions specified in this protocol
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements
Ability to swallow study drugs and to comply with study requirements throughout the study
Be able to comply with the requirements of the entire study.
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements.
Patient is unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator that the patient is not suitable for participation in the study.
Participant must be able to adhere to study visit/procedure schedule and protocol requirements
Participant unwilling to adhere to study visit/procedure schedule and protocol requirements
Can understand and voluntarily sign an informed consent form prior to any study-related assessments or procedures, and are able to adhere to the study visit schedule and other protocol requirements
Ability to adhere with the study visit schedule and other protocol procedures
Must be able and willing to adhere to protocol requirements, visits and vaccination timeline
Ability to voluntarily sign consent for and adhere to the entire study visit schedule and all protocol requirements
Be willing and able to comply with the protocol-required visit schedule and visit requirements and provide written informed consent
Able to adhere to study visit schedule and other protocol requirements.
Able to adhere to study visit schedule and other protocol requirements
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Willing and able to comply with all study requirements, including treatment, timing and nature of required assessments
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Ability and willingness to comply with the requirements of the study protocol.
Patients must agree/be able to comply with all protocol specific requirements
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Judgment by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions and requirements
Able to comply with the study protocol, in the investigator’s judgment
Ability to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Ability and willingness to comply with the requirements of the study protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients should be able to swallow enzalutamide and comply with study requirements
Non-compliance: subjects who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study will be considered non-compliant
Ability and willingness to comply with the requirements of the study protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Non-compliance: if it is the opinion of the investigator that a subject may be unable to comply with the safety monitoring requirements of the study, they will be excluded
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Be able and willing to adhere to the study visit schedule and other protocol requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Medically and psychologically able to comply with all study requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Medically and psychologically able to comply with all study requirements
Willing to adhere to the study visit schedule and prohibitions and restrictions specified in this study protocol
Willing to adhere to the study visit schedule and the prohibitions and restrictions specified in this protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Ability and willingness to comply with all study requirements
Subject is willing and able to adhere to the study visit schedule and other protocol requirements.
Vasectomy or surgical castration ? 6 months prior to Screening. 13. Subjects able to swallow study medication 14. Subjects able to comply with study requirements
Able to adhere to the study visit schedule and other protocol requirements Disease Specific 4. Histologically or cytologically confirmed Stage IIIB or IV squamous cell Non Small Cell Lung Cancer at study entry.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Subject is able to adhere to the study visit schedule and other protocol requirements.
The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment. Inclusion Criteria:
The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment.
Subject is willing and able to adhere to the study visit schedule and other protocol requirements
Willing and able to adhere to the study visit schedule and other protocol requirements. MDS Cohort:
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Willing and able to give written informed consent and comply with study visit schedule
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Able to adhere to the study visit schedule and other protocol requirements.
Willing and able to adhere to the study visit schedule and other protocol requirements.
Able to adhere to the study visit schedule and other protocol requirements.
Ability to adhere to the study visit schedule and all protocol requirements;
Able to adhere to the study visit schedule and other protocol requirements
Willing to adhere to the study visit schedule and the prohibitions and restrictions specified in this protocol
Willing and able to give written informed consent and comply with study visit schedule.
Willing to adhere to the study visit schedule and the prohibitions and restrictions specified in this protocol
Understand and voluntarily sign an informed consent prior to any study-related assessments or procedures are conducted and are able adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Willingness to follow study visit schedule, pregnancy precautions and other protocol requirements.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements and/or follow-up studies of this trial
The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment.
Patients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the study
Patient is able and willing to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Patient must be willing to give written informed consent and must be able to adhere to dosing and visit schedules, and meet all study requirements.
Patient must be able to adhere to the study visit schedule and other protocol requirements
Participant is willing to adhere to the study visit schedule and other protocol requirements.
Must be able to adhere to the study visit schedule and other protocol requirements
Ability and willingness to comply with the requirements of the study protocol
Subject must be able to swallow study drug and comply with study requirements.
Ability and willingness to comply with the requirements of the study protocol
Willing and able to comply with all study requirements, including treatment and required assessments
Subject must be able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements
Patients must meet the following criteria on screening examination to be eligible to participate in the study; all laboratory assessments should be performed within 21 days of initiation of protocol therapy unless otherwise specified; subject is, in the investigator’s opinion, willing and able to comply with the protocol requirements
Patient is willing and able to participate in the study and comply with all study requirements.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Able to understand and voluntarily sign the informed consent form, and able to comply with the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
As judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements
Is willing and able to adhere to the study visit schedule and other protocol requirements.
Ability to provide informed written consent and be able to adhere to the study visit schedule and other protocol requirements
Subjects unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Research participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule and other protocol requirements
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Individuals not willing to comply with the procedural requirements of this protocol
Able to adhere to the study visit schedule and other protocol requirements
Ability to voluntarily sign consent for and adhere to the entire study visit schedule and all protocol requirements
Subject is able to swallow the study drug and comply with study requirements.
The patient or parent(s)/guardian(s) is/are unable to comply with the study visit schedule and other protocol requirements, in the opinion of the investigator.
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Ability and willingness to comply with the requirements of the study protocol
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Individuals not willing to comply with the procedural requirements of this protocol
Willing/able to adhere to the prohibitions and restrictions specified in this protocol
Able to swallow the study drug and comply with study requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule (ie, clinic visits at the study sites are mandatory, unless noted otherwise for particular study visits) and other protocol requirements.
Patient is willing and able to adhere to the study visit schedule and other protocol requirements
Ability to adhere to the study visit schedule and other protocol requirements
Subjects must agree to adhere to all study requirements, including birth control measures and pregnancy testing, visit schedule, outpatient treatment, required concomitant medications, and laboratory monitoring
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Patients who, in the opinion of the investigator, are unable to comply with the requirements of the study protocol are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Must be able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to swallow the study drug and comply with study requirements
Able to adhere to study schedule and other protocol requirements
Willing and able to adhere to the protocol requirements, including but not limited to study drug dosing, study drug visits, medication and treatment restrictions, and laboratory tests
Was willing and able to adhere to the study visit schedule and other protocol requirements.
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements.
Must be able to comply with study and follow up requirements
Willing to adhere to and comply with all prohibitions and restrictions specified in the protocol
Able to adhere to the study visit schedule and other protocol requirements
Subjects must be willing to adhere to the study visit schedule and other protocol requirements
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligible
Patient must be able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Ability and willingness to comply with the requirements of the study protocol
Patient must be willing and able to adhere to the prohibitions and restrictions specified in this protocol.
Able to adhere to the study visit schedule and other protocol requirements
Must be able to adhere to the study visit schedule and other protocol requirements.
Must be able to adhere to the study visit schedule and other protocol requirements.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Subject is able to adhere to the study visit schedule and other protocol requirements
Sufficient mental capacity to comply with the protocol requirements,
Willing and able to participate in the trial and comply with all trial requirements.
Participant is willing and able to comply with the requirements of the protocol
Ability and willingness to comply with the requirements of the study protocol
Able to swallow the study drug as prescribed and comply with study requirements
Willing and able to participate in the trial and comply with all trial requirements
Participant is willing and able to comply with the requirements of the protocol
Subject is willing and able to comply with the requirements of the protocol.
Ability to swallow study drugs and to comply with study requirements throughout the study.
Subject is unlikely to comply with the protocol requirements, instructions and study-related restrictions
Able to adhere to the study visit schedule and other protocol requirements.
Able to comply with the treatment schedule
Subject is able to understand and comply with protocol requirements and instructions
Ability to adhere to the study visit schedule and other protocol requirements
Willing and able to participate in the trial and comply with all trial requirements.
As judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements
Inability to co-operate with the study visit schedule and other requirements of the protocol
Ability and willingness to comply with the requirements of the study protocol
Able to adhere to the study visit schedule and other protocol requirements.
Able to adhere to the study visit schedule and other protocol requirements
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
The patient must be willing and able to comply with study requirements, remain at the clinic, and be willing and able to return to the clinic for the follow-up evaluation as specified in this protocol during the study period.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Able to adhere to the study visit schedule and other protocol requirements
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Willing and able to comply with post-operative treatment protocol and follow-up visit schedule.
Able to adhere to the study visit schedule and other protocol requirements. Disease Specific
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Able to adhere to the study visit schedule and other protocol requirements
Able to comply with study visit schedule and assessments.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Able and willing to comply with protocol requirements, in the opinion of the investigator.
Must be able and willing to comply with the study visit schedule and study procedures.
Must be able to understand and comply with protocol requirements and instructions
Patients must be willing and able to adhere to the prohibitions and restrictions specified in this protocol
Subject is able and willing to comply with the requirements of the protocol.
Unable to comply with study requirements in the opinion of the Investigator.
Participant is willing and able to comply with the requirements of the protocol
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to study visit schedule and other protocol requirements
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
Able to adhere to the study visit schedule and requirements of the protocol
Able to understand and comply with the requirements of the protocol
Participants who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
Able to adhere to the study visit schedule and other protocol requirements
Able to adhere to the study visit schedule and other protocol requirements
Patients must be willing and able to adhere to the prohibitions and restrictions specified in this protocol
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Willing and able to meet all study requirements
Subjects must be willing to adhere to the study visit schedule and other protocol requirements
Able to swallow enzalutamide and comply with study requirements
Able to adhere to study schedule and other protocol requirements
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Be willing/able to adhere to the prohibitions and restrictions specified in this protocol
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Willing and able to do all study requirements
Willing and able to meet all study requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Are willing and able to complete study requirements
Willing and able to meet all study requirements
Able and willing to give informed assent and comply with study requirements
Willing and able to meet all study requirements
Willing and able to comply with the requirements of the protocol
Ability to understand and comply with the requirements of this study
Able to adhere to the study visit schedule and other protocol requirements
Willingness to adhere to the study visit schedule and prohibitions as specified in this protocol
Patient that is not able to understand or to comply with the study instructions and requirements or has a history of non-compliance to the medical regimen
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patient is able to understand and comply with protocol requirements and instructions
Any patient, in the opinion of the investigator, who is unable or unlikely to comply fully with the study requirements or procedures for any reason
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Unwillingness to comply with the requirements of the protocol
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Non-compliance defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Willing to follow protocol requirements
Willingness to sign informed consent and comply with all protocol requirements
Able to co-operate with the investigator and to comply with the requirements of the entire study.
Patient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Be able to adhere to the study visit schedule and other protocol requirements.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Ability to comprehend and comply with the requirements of the Study
Subject is willing and able to adhere to the study visit schedule and other protocol requirements.
Subjects who the investigator believes can and will comply with the requirements of the protocol.
Has any condition that interferes with the ability of the subject to understand or comply with the requirements of the study.
Subjects who the investigator believes can and will comply with the requirements of the protocol
Subjects provide signed informed consent and confirm that they are able and willing to comply with all protocol requirements. Cohort A Only:
Willing and able to provide informed consent and adhere to the study visit schedule and plan as specified in this protocol
Able to understand study requirements
Willing to comply with protocol requirements
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patient is willing to comply with protocol requirements
Willing and able to follow the protocol requirements.
Not willing to comply with the procedural requirements of this protocol
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Women willing to comply with protocol requirements
Patients willing to comply with protocol requirements
Able to adhere to study visit schedule and other protocol requirements including follow-up for survival assessment
Judgment by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions and requirements
Patients must be able to comply with the safety monitoring of the study in the opinion of the investigator
As judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements
Willingness to comply with the requirements of the study
As judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements
Required observations: Subjects who in opinion of investigator may not be able to comply with required safety and monitoring requirements are not eligible
Patients who are able to comply with the protocol.
Willing and able to adhere to the study visit schedule and other protocol requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
